Glucose B.Braun

Glucose B.Braun is an intravenous solution containing the active ingredient glucose monohydrate. It is supplied in a sterile liquid form intended for parenteral administration. The product conforms to European Union pharmaceutical standards and is classified as an excipient rather than a therapeutic drug. Glucose B.Braun provides a readily available source of glucose for cellular energy metabolism when infused into the bloodstream of patients during treatment.

Glucose B.Braun is used primarily to restore or maintain blood glucose concentrations in clinical settings where oral intake is not feasible.

- Provides rapid glucose supplementation during surgery or anesthesia. - Supports energy needs in patients receiving total parenteral nutrition. - Corrects hypoglycemia in emergency or critical‑care situations. - Serves as a carrier solution for compatible intravenous medications. - Assists in metabolic testing protocols that require controlled glucose infusion.

When administered intravenously, glucose monohydrate may be associated with a range of observed effects, most of which are related to its metabolic role.

Common: - Transient hyperglycemia - Mild electrolyte shift (e.g., potassium) - Local irritation at the infusion site - Nausea or vomiting if infused rapidly

Serious: - Severe hyperglycemia leading to osmotic diuresis - Hypersensitivity reactions such as rash or anaphylaxis - Fluid overload in patients with compromised cardiac function - Metabolic acidosis in cases of massive infusion

Clinicians should consider several precautionary measures before selecting Glucose B.Braun for intravenous therapy.

- Verify patient’s baseline blood glucose and adjust infusion rate accordingly. - Assess renal and cardiac function to avoid fluid overload or electrolyte imbalance. - Use aseptic technique to prevent catheter‑related infections. - Avoid concurrent administration with high‑dose insulin without monitoring. - Monitor serum electrolytes, especially potassium and phosphate, during prolonged infusion. - Consider contraindication in patients with known hypersensitivity to glucose solutions.

Glucose B.Braun can interact with other agents administered intravenously; awareness of these interactions helps maintain safety.

Avoid: - High‑dose insulin boluses without glucose supplementation, which may precipitate severe hypoglycemia. - Hyperosmolar dextrose solutions combined with other hypertonic fluids, increasing risk of osmotic injury. - Medications that require a low‑glucose environment, such as certain chemotherapeutic agents, where excess glucose may reduce efficacy.

Use with caution: - Diuretics that affect electrolyte balance, requiring close monitoring of potassium. - Calcium channel blockers, as rapid glucose infusion can influence hemodynamics. - Blood products, because glucose can affect the stability of some components.